HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Can restrictions on reimbursement for anti-ulcer drugs decrease Medicaid pharmacy costs without increasing hospitalizations?

AbstractOBJECTIVE:
To examine the impact of a policy restricting reimbursement for Medicaid anti-ulcer drugs on anti-ulcer drug use and peptic-related hospitalizations.
DATA SOURCES/STUDY SETTING:
In addition to U.S. Census Bureau data, all of the following from Florida: Medicaid anti-ulcer drug claims data, 1989-1993; Medicaid eligibility data, 1989-1993; and acute care nonfederal hospital discharge abstract data (Medicaid and non-Medicaid), 1989-1993.
STUDY DESIGN:
In this observational study, a Poisson multiple regression model was used to compare changes, after policy implementation, in Medicaid reimbursement for prescription anti-ulcer drugs as well as hospitalization rates between pre- and post-implementation periods in Medicaid versus non-Medicaid patients hospitalized with peptic ulcer disease.
PRINCIPAL FINDINGS:
Following policy implementation, the rate of Medicaid reimbursement for anti-ulcer drugs decreased 33 percent (p < .001). No associated increase occurred in the rate of Medicaid peptic-related hospitalizations.
CONCLUSIONS:
Florida's policy restricting Medicaid reimbursement for anti-ulcer drugs was associated with a substantial reduction in outpatient anti-ulcer drug utilization without any significant increase in the rate of hospitalization for peptic-related conditions.
AuthorsD M Cromwell, E B Bass, E P Steinberg, Y Yasui, W J Ravich, T R Hendrix, S F McLeod, R D Moore
JournalHealth services research (Health Serv Res) Vol. 33 Issue 6 Pg. 1593-610 (Feb 1999) ISSN: 0017-9124 [Print] United States
PMID10029499 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Anti-Ulcer Agents
Topics
  • Adolescent
  • Adult
  • Anti-Ulcer Agents (economics, therapeutic use)
  • Child
  • Child, Preschool
  • Cost Control
  • Drug Costs (statistics & numerical data)
  • Drug Utilization
  • Female
  • Florida
  • Hospitalization (statistics & numerical data, trends)
  • Humans
  • Infant
  • Male
  • Medicaid (economics)
  • Middle Aged
  • Organizational Policy
  • Peptic Ulcer (drug therapy, economics)
  • Regression Analysis
  • Reimbursement Mechanisms (economics, statistics & numerical data, trends)
  • United States

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: